Analysis of how antigen mutations disrupt antibody binding interactions toward enabling rapid and reliable antibody repurposing.

IF 5.6 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL mAbs Pub Date : 2025-12-01 Epub Date: 2024-12-17 DOI:10.1080/19420862.2024.2440586
Sumaiya Islam, Varun M Chauhan, Robert J Pantazes
{"title":"Analysis of how antigen mutations disrupt antibody binding interactions toward enabling rapid and reliable antibody repurposing.","authors":"Sumaiya Islam, Varun M Chauhan, Robert J Pantazes","doi":"10.1080/19420862.2024.2440586","DOIUrl":null,"url":null,"abstract":"<p><p>Antibody repurposing is the process of changing a known antibody so that it binds to a mutated antigen. One of the findings to emerge from the Coronavirus Disease 2019 (COVID-19) pandemic was that it was possible to repurpose neutralizing antibodies for Severe Acute Respiratory Syndrome, a related disease, to work for COVID-19. Thus, antibody repurposing is a possible pathway to prepare for and respond to future pandemics, as well as personalizing cancer therapies. For antibodies to be successfully repurposed, it is necessary to know both how antigen mutations disrupt their binding and how they should be mutated to recover binding, with this work describing an analysis to address the first of these topics. Every possible antigen point mutation in the interface of 246 antibody-protein complexes were analyzed using the Rosetta molecular mechanics force field. The results highlight a number of features of how antigen mutations affect antibody binding, including the effects of mutating critical hotspot residues versus other positions, how many mutations are necessary to be likely to disrupt binding, the prevalence of indirect effects of mutations on binding, and the relative importance of changing attractive versus repulsive energies. These data are expected to be useful in guiding future antibody repurposing experiments.</p>","PeriodicalId":18206,"journal":{"name":"mAbs","volume":"17 1","pages":"2440586"},"PeriodicalIF":5.6000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11657118/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"mAbs","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/19420862.2024.2440586","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/17 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Antibody repurposing is the process of changing a known antibody so that it binds to a mutated antigen. One of the findings to emerge from the Coronavirus Disease 2019 (COVID-19) pandemic was that it was possible to repurpose neutralizing antibodies for Severe Acute Respiratory Syndrome, a related disease, to work for COVID-19. Thus, antibody repurposing is a possible pathway to prepare for and respond to future pandemics, as well as personalizing cancer therapies. For antibodies to be successfully repurposed, it is necessary to know both how antigen mutations disrupt their binding and how they should be mutated to recover binding, with this work describing an analysis to address the first of these topics. Every possible antigen point mutation in the interface of 246 antibody-protein complexes were analyzed using the Rosetta molecular mechanics force field. The results highlight a number of features of how antigen mutations affect antibody binding, including the effects of mutating critical hotspot residues versus other positions, how many mutations are necessary to be likely to disrupt binding, the prevalence of indirect effects of mutations on binding, and the relative importance of changing attractive versus repulsive energies. These data are expected to be useful in guiding future antibody repurposing experiments.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
分析抗原突变如何破坏抗体结合相互作用,以实现快速可靠的抗体再利用。
抗体再利用是改变已知抗体,使其与突变抗原结合的过程。2019年冠状病毒病(COVID-19)大流行的一项发现是,有可能将针对相关疾病严重急性呼吸系统综合征(sars)的中和抗体重新用于COVID-19。因此,抗体再利用是一种可能的途径,可用于准备和应对未来的流行病,以及个性化癌症治疗。为了成功地改变抗体的用途,有必要了解抗原突变如何破坏它们的结合,以及它们应该如何突变以恢复结合,本工作描述了解决第一个主题的分析。利用Rosetta分子力学力场分析246个抗体-蛋白复合物界面上可能存在的抗原点突变。这些结果突出了抗原突变如何影响抗体结合的一些特征,包括突变关键热点残基对其他位置的影响,需要多少突变才能可能破坏结合,突变对结合的间接影响的普遍程度,以及改变吸引能和排斥能的相对重要性。这些数据有望指导未来的抗体再利用实验。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
mAbs
mAbs 工程技术-仪器仪表
CiteScore
10.70
自引率
11.30%
发文量
77
审稿时长
6-12 weeks
期刊介绍: mAbs is a multi-disciplinary journal dedicated to the art and science of antibody research and development. The journal has a strong scientific and medical focus, but also strives to serve a broader readership. The articles are thus of interest to scientists, clinical researchers, and physicians, as well as the wider mAb community, including our readers involved in technology transfer, legal issues, investment, strategic planning and the regulation of therapeutics.
期刊最新文献
T cell margination: investigating the detour of T cells following forimtamig treatment in humanized mice. Analysis of how antigen mutations disrupt antibody binding interactions toward enabling rapid and reliable antibody repurposing. Antibodies to watch in 2025. Online native hydrophobic interaction chromatography-mass spectrometry of antibody-drug conjugates. Prediction of protein biophysical traits from limited data: a case study on nanobody thermostability through NanoMelt.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1